{"content":"<li class=\"n-box-item date-title\" data-end=\"1522382399\" data-start=\"1522296000\" data-txt=\"Monday, December 23, 2019\">Thursday, March 29, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3342751\" data-ts=\"1522366161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUM\" target=\"_blank\">HUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342751-humana-up-13_5-on-report-walmart-eyes-possible-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Humana up 13.5% on report Walmart eyes possible acquisition</a></h4><ul>     <li>Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) is jumping in the late session, <font color='green'>up 13.5%</font>, on a <i>Wall Street Journal</i> report that Walmart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) is seeking closer ties that <a href=\"https://www.wsj.com/articles/walmart-in-early-stage-acquisition-talks-with-humana-1522365618\" target=\"_blank\">could include an acquisition</a>.</li>     <li><a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> is <font color='red'>off 1.1%</font> after hours.</li>     <li>This would be the latest ground shift in healthcare service provision, and a sizable one considering Humana's $37B market cap -- which would make it Walmart's biggest deal by far.</li>     <li>Other movers after hours: <a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color='green'>+0.8%</font>; <a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color='green'>+2.7%</font>; <a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color='green'>+2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342751\" data-linked=\"Humana up 13.5% on report Walmart eyes possible acquisition\" data-tweet=\"$HUM $HUM $WMT - Humana up 13.5% on report Walmart eyes possible acquisition https://seekingalpha.com/news/3342751-humana-up-13_5-on-report-walmart-eyes-possible-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3342751-humana-up-13_5-on-report-walmart-eyes-possible-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>120&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342744\" data-ts=\"1522362513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342744-tesla-recalls-123k-model-s-cars-over-potential-power-steering-failure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla recalls 123K Model S cars over potential power steering failure</a></h4><ul>     <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color='red'>-3.1%</font> after-hours on news that the company is voluntarily <a href=\"https://www.wsj.com/articles/tesla-recalls-123-000-model-s-cars-over-bolt-issue-1522361482\" target=\"_blank\">recalling ~123K Model S sedans</a> globally after discovering certain corroding bolts in cold weather climates could lead to a power-steering failure.</li>     <li>TSLA says the recall, believed to be the company&rsquo;s largest ever, applies to Model S sedans built before April 2016; the company sold ~280K total vehicles through the end of last year.</li>     <li>&ldquo;There have been no injuries or accidents due to this component, despite accumulating more than a billion miles of driving,&rdquo; says an email the company is sending to customers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342744\" data-linked=\"Tesla recalls 123K Model S cars over potential power steering failure\" data-tweet=\"$TSLA - Tesla recalls 123K Model S cars over potential power steering failure https://seekingalpha.com/news/3342744-tesla-recalls-123k-model-s-cars-over-potential-power-steering-failure?source=tweet\" data-url=\"https://seekingalpha.com/news/3342744-tesla-recalls-123k-model-s-cars-over-potential-power-steering-failure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>514&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342722\" data-ts=\"1522356603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UA\" target=\"_blank\">UA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342722-under-armour-discloses-data-breach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour discloses data breach</a></h4><ul>     <li>Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>, <a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) falls sharply after the company <a href=\"https://seekingalpha.com/pr/17116237-armour-notifies-myfitnesspal-users-data-security-issue\" target=\"_blank\">discloses</a> that an unauthorized party acquired data associated with MyFitnessPal user accounts in late February.</li>     <li>The company says it took quick action to determine the nature and scope of the issue and alert the MyFitnessPal community of the incident.</li><li>Under Armour learned of the exposure on March 25.</li><li>UA&nbsp;<font color='red'>-1.75%&nbsp;</font>AH. UAA&nbsp;<font color='red'>-1.88%</font>. Both classes were showing a larger loss earlier in the AH session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342722\" data-linked=\"Under Armour discloses data breach\" data-tweet=\"$UA $UA $UAA - Under Armour discloses data breach https://seekingalpha.com/news/3342722-under-armour-discloses-data-breach?source=tweet\" data-url=\"https://seekingalpha.com/news/3342722-under-armour-discloses-data-breach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342708\" data-ts=\"1522355839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SENS\" target=\"_blank\">SENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342708-fda-ad-com-backs-senseonics-eversense-cgm-system-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA Ad Com backs Senseonics Eversense CGM system; shares up 2% after hours</a></h4><ul><li>In a unanimous 8 - 0 vote, the FDA's Clinical Chemistry and Clinical Toxicology Devices Panel recommends approval for Senseonics' (NYSEMKT:<a href='https://seekingalpha.com/symbol/SENS' title='Senseonics Holdings'>SENS</a>) Eversense CGM system, designed to provide continuous blood sugar levels for 90 days.</li><li>Shares are up&nbsp;<font color='green'>2%&nbsp;</font>after hours on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341916-fda-ad-com-thursday-senseonics-eversense-cgm-shares-5-percent-data-accuracy-questions\" target=\"_blank\">FDA Ad Com Thursday for Senseonics Eversense CGM; shares down 5% on data accuracy questions</a> (March 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342708\" data-linked=\"FDA Ad Com backs Senseonics Eversense CGM system; shares up 2% after hours\" data-tweet=\"$SENS - FDA Ad Com backs Senseonics Eversense CGM system; shares up 2% after hours https://seekingalpha.com/news/3342708-fda-ad-com-backs-senseonics-eversense-cgm-system-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3342708-fda-ad-com-backs-senseonics-eversense-cgm-system-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342704\" data-ts=\"1522355702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNES\" target=\"_blank\">SNES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342704-senestech-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SenesTech beats by $0.03, beats on revenue</a></h4><ul><li>SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a>): FY EPS of -$1.12 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $0.05M (-83.9% Y/Y) <font color='green'>beats by $0.02M</font>.</li><li>Shares <font color='green'>+3.24%</font>.</li><li><a href='https://seekingalpha.com/pr/17116170-senestech-announces-year-end-2017-financial-operational-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3342704\" data-linked=\"SenesTech beats by $0.03, beats on revenue\" data-tweet=\"$SNES - SenesTech beats by $0.03, beats on revenue https://seekingalpha.com/news/3342704-senestech-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3342704-senestech-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342690\" data-ts=\"1522354921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342690-ft-facebook-was-told-cambridge-app-might-sell-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FT: Facebook was told Cambridge app might sell data</a></h4><ul>   <li>Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) <a href=\"https://www.ft.com/content/6ef3766a-3368-11e8-ac48-10c6fdc22f03\" target=\"_blank\">was made aware</a> that the app at the center of the Cambridge Analytica data leak could sell its data to third parties, in violation of its own platform policies, the <i>Financial Times</i> reports.</li>    <li>The company was sent terms and conditions for a second version of the personality-survey app that discussed the potential data transfers, but Facebook was using an automated process to accept updates -- raising the possibility that no employee saw the app's new policies.</li>    <li>That second version departed starkly from an earlier version that said &ldquo;users will be informed that the data will be carefully protected and never used for commercial purposes.\"</li>    <li>&ldquo;There were a lot of apps at the time that were pulling lots of data &mdash; including from friend networks &mdash; and Facebook wasn&rsquo;t exactly proactive in asking questions or finding out where that data went,&rdquo; said Christopehr Wylie, the Cambridge Analytica whistleblower.</li>    <li>In a rebound today, Facebook shares closed <font color='green'>up 4.4%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342654-facebook-trial-photo-biometrics-set-july\" target=\"_blank\">Facebook trial over photo biometrics set for July</a> (Mar. 29 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342386-another-privacy-move-facebook-ending-partner-categories\" target=\"_blank\">In another privacy move, Facebook ending Partner Categories</a> (Mar. 28 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342116-facebook-make-privacy-control-easier-shares-1_6-percent-premarket\" target=\"_blank\">Facebook to make privacy control easier; shares up 1.6% premarket</a> (Mar. 28 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342690\" data-linked=\"FT: Facebook was told Cambridge app might sell data\" data-tweet=\"$FB - FT: Facebook was told Cambridge app might sell data https://seekingalpha.com/news/3342690-ft-facebook-was-told-cambridge-app-might-sell-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3342690-ft-facebook-was-told-cambridge-app-might-sell-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342678\" data-ts=\"1522353925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342678-alnylam-and-ionis-in-red-on-positive-late-stage-data-on-pfizers-amyloidosis-drug-tafamidis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam and Ionis in the red on positive late-stage data on Pfizer&#39;s amyloidosis drug tafamidis</a></h4><ul><li>Alnylam Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='red'>-8.2%</font>) and Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-4.1%</font>) were both under pressure on increased volume today in apparent response to Pfizer's announcement of successful Phase 3 data on tafamidis in a subtype of amyloidosis.</li><li>Alnylam and Ionis have been in a horse race with their respective candidates for the hereditary form of amyloidosis. Both of their U.S. marketing applications are under FDA review.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342647-pfizers-tafamidis-successful-late-stage-study-rare-heart-failure-condition\" target=\"_blank\">Pfizer's tafamidis successful in late-stage study in rare heart failure condition</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342678\" data-linked=\"Alnylam and Ionis in the red on positive late-stage data on Pfizer&#39;s amyloidosis drug tafamidis\" data-tweet=\"$ALNY $ALNY $IONS - Alnylam and Ionis in the red on positive late-stage data on Pfizer&#39;s amyloidosis drug tafamidis https://seekingalpha.com/news/3342678-alnylam-and-ionis-in-red-on-positive-late-stage-data-on-pfizers-amyloidosis-drug-tafamidis?source=tweet\" data-url=\"https://seekingalpha.com/news/3342678-alnylam-and-ionis-in-red-on-positive-late-stage-data-on-pfizers-amyloidosis-drug-tafamidis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342679\" data-ts=\"1522353886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AETI\" target=\"_blank\">AETI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342679-american-electric-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Electric reports Q4 results</a></h4><ul><li>American Electric (NASDAQ:<a href='https://seekingalpha.com/symbol/AETI' title='American Electric Technologies, Inc.'>AETI</a>): Q4 EPS of $0.26</li><li>Revenue of $12.9M (+37.2% Y/Y)</li><li>Shares <font color='green'>+4.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17115296-aeti-reports-fourth-quarter-fiscal-year-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3342679\" data-linked=\"American Electric reports Q4 results\" data-tweet=\"$AETI $SLNG - American Electric reports Q4 results https://seekingalpha.com/news/3342679-american-electric-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3342679-american-electric-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342675\" data-ts=\"1522353388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342675-boeing-priced-for-worst-case-scenario-china-action-unlikely-baml-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing priced for worst-case scenario as China action unlikely, BAML says</a></h4><ul>     <li>Boeing's (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+2.4%</font>) big move has <a href=\"https://www.marketwatch.com/story/dows-nearly-300-point-rise-powered-by-rallies-in-apple-boeing-stocks-in-late-morning-trade-2018-03-29\" target=\"_blank\">contributed nearly 70 points</a> to the late-afternoon advance of the Dow Jones average, which recently had climbed as much as 450 points.</li>     <li>Boeing shares had dropped ~8% in March as investors have been worried about a potential trade war with China, which accounted for more than 25% of the company's deliveries in 2017.</li>     <li>BofA Merrill Lynch analyst Ronald Epstein says BA shares are <a href=\"https://finance.yahoo.com/news/boeing-co-ba-stock-priced-113416600.html\" target=\"_blank\">pricing in an unlikely worst-case scenario</a>, and although China could target a wide range of U.S. products as part of its tariff retaliation, \"aircraft are not soybeans,\" and the Boeing-Airbus essential duopoly over the global aircraft industry would make it difficult for China to replace Boeing's business.</li>     <li>\"Given the global intertwined industry structure of aerospace, record industry backlogs, limited manufacturing capacity and strategic importance of air travel to economic growth, we think it is unlikely China will act impulsively to implement offensive trade barriers in aerospace but rather will take a more patient, long-term view,\" Epstein writes.</li>     <li>BAML rates Boeing a Buy with a $470 price target.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342675\" data-linked=\"Boeing priced for worst-case scenario as China action unlikely, BAML says\" data-tweet=\"$BA - Boeing priced for worst-case scenario as China action unlikely, BAML says https://seekingalpha.com/news/3342675-boeing-priced-for-worst-case-scenario-china-action-unlikely-baml-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3342675-boeing-priced-for-worst-case-scenario-china-action-unlikely-baml-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342672\" data-ts=\"1522352375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342672-galectin-up-27-fda-meeting-early-may-to-clarify-phase-3-plan-for-nash-candidate-gr-mdminus-02\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin up 27%, FDA meeting early May to clarify Phase 3 plan for NASH candidate GR-MD-02</a></h4><ul><li>Galectin (<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+27%</font>) <a href=\"https://seekingalpha.com/pr/17115464-galectin-therapeutics-reports-2017-financial-results-provides-business-update\" target=\"_blank\">updated </a>investors earlier today on expected key milestones this year:</li><li>It will meet with the FDA in early May to present results from the Phase 2b NASH-CX study of lead candidate GR-MD-02 that missed the primary endpoint but did show a promising treatment effect in a subset of NASH patients (without esophageal varices). The objective is to clarify the Phase 3 program.</li><li>It has filed a request with the FDA seeking Breakthrough Therapy status for GR-MD-02 for the treatment of NASH cirrhosis without esophageal varices (dilated veins in the esophagus due to portal hypertension).</li><li>Discussions with potential development partners are ongoing.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316321-galectins-gr-mdminus-02-shows-treatment-benefit-subset-nash-patients-mid-stage-study-shares\" target=\"_blank\">Galectin's GR-MD-02 shows treatment benefit in subset of NASH patients in mid-stage study; shares ahead 27% premarket</a> (Dec. 5, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342672\" data-linked=\"Galectin up 27%, FDA meeting early May to clarify Phase 3 plan for NASH candidate GR-MD-02\" data-tweet=\"$GALT - Galectin up 27%, FDA meeting early May to clarify Phase 3 plan for NASH candidate GR-MD-02 https://seekingalpha.com/news/3342672-galectin-up-27-fda-meeting-early-may-to-clarify-phase-3-plan-for-nash-candidate-gr-mdminus-02?source=tweet\" data-url=\"https://seekingalpha.com/news/3342672-galectin-up-27-fda-meeting-early-may-to-clarify-phase-3-plan-for-nash-candidate-gr-mdminus-02\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342666\" data-ts=\"1522350021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPTN\" target=\"_blank\">NPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342666-technology-top-5-gainers-losers-of-3-00-pm-03-29-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (03/29/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SHSP' title='SharpSpring, Inc.'>SHSP</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='red'>-48%</font>. <a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold Golden Lines Ltd.'>IGLD</a> <font color='red'>-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342666\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (03/29/2018)\" data-tweet=\"$NPTN $NPTN $MEET - Technology - Top 5 Gainers / Losers as of 3:00 PM (03/29/2018) https://seekingalpha.com/news/3342666-technology-top-5-gainers-losers-of-3-00-pm-03-29-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342666-technology-top-5-gainers-losers-of-3-00-pm-03-29-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342662\" data-ts=\"1522348827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342662-buffett-ge-deal-rumor-dismissed-j-p-morgans-tusa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buffett-GE deal rumor dismissed by J.P. Morgan&#39;s Tusa</a></h4><ul>     <li>J.P. Morgan's Stephen Tusa <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11440921/jpmorgan-dismisses-buffett-ge-buyout-rumor\" target=\"_blank\">reiterates his Underweight rating</a> and $11 price target for General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-2%</font>) shares following this week's speculation that Warren Buffett <a href=\"https://seekingalpha.com/news/3341943-ge-plus-5-percent-rumors-buffett-investment\" target=\"_blank\">might acquire a stake in the company</a>.</li>     <li>Tusa says Buffett's past involvement in GE ended up being \"wrong from a timing and stock value perspective,\" and he \"[scratches his head] why, if things are not so bad here, GE would need Berkshire's capital or validation.\"</li>     <li>The analyst says if Buffett were to step in, it likely would involve a preferred or convertible stake similar to his previous GE position.</li>     <li>GE tends to react in a more volatile way to rumors than other stocks due to the number of in-the-money short sellers and dip buyers who are closely watching the stock, Tusa says, but GE's long-term investment thesis will remain bearish until the company&rsquo;s fundamentals show signs of prolonged improvement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342662\" data-linked=\"Buffett-GE deal rumor dismissed by J.P. Morgan&#39;s Tusa\" data-tweet=\"$GE - Buffett-GE deal rumor dismissed by J.P. Morgan&#39;s Tusa https://seekingalpha.com/news/3342662-buffett-ge-deal-rumor-dismissed-j-p-morgans-tusa?source=tweet\" data-url=\"https://seekingalpha.com/news/3342662-buffett-ge-deal-rumor-dismissed-j-p-morgans-tusa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342661\" data-ts=\"1522348184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342661-white-house-says-trump-isnt-discussing-new-actions-on-amazon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">White House says Trump isn&#39;t discussing new actions on Amazon</a></h4><ul><li>        White House spokeswoman Lindsay Walters says President Trump isn&rsquo;t discussing any new actions against Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>).</li><li>               Walters says Trump&rsquo;s tweet this morning expressed frustration with some Amazon customers not paying sales taxes.&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='green'>up 0.8%</font>&nbsp;and on the recovery from the losses this morning.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3342661\" data-linked=\"White House says Trump isn&#39;t discussing new actions on Amazon\" data-tweet=\"$AMZN - White House says Trump isn&#39;t discussing new actions on Amazon https://seekingalpha.com/news/3342661-white-house-says-trump-isnt-discussing-new-actions-on-amazon?source=tweet\" data-url=\"https://seekingalpha.com/news/3342661-white-house-says-trump-isnt-discussing-new-actions-on-amazon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342657\" data-ts=\"1522347612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342657-apple-releases-ios-11_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple releases iOS 11.3</a></h4><ul><li>           Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) <a href=\"https://www.cnbc.com/2018/03/29/ios-11-point-3-released-with-battery-life-changes-new-health-record-feature.html\" target=\"_blank\">releases</a> iOS 11.3, which includes battery management changes due to the controversy over throttling older devices. </li><li> The operating system will now show if Apple is limiting a phone&rsquo;s performance to spare battery life and gives the option of turning that feature off. </li><li> The Health app now has Health Record for downloading health records and data from participating physicians and hospitals. </li><li> The new Business Chat section of iMessage lets users chat with partnered businesses (so far includes the likes Lowe&rsquo;s, Wells Fargo, Hilton, and Discover) for support and purchasing. </li><li> Apple shares are&nbsp;<font color='green'>up 2.6%</font>&nbsp;to $170.87.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3324881-apple-previews-ios-11_3-battery-management-features-health-records\" target=\"_blank\">Apple previews iOS 11.3 with battery management features, health records</a> (Jan. 24)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320367-apples-apology-letter-consumers-includes-29-batteries\" target=\"_blank\">Apple's apology letter to consumers includes $29 batteries</a> (Dec. 28, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342657\" data-linked=\"Apple releases iOS 11.3\" data-tweet=\"$AAPL - Apple releases iOS 11.3 https://seekingalpha.com/news/3342657-apple-releases-ios-11_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3342657-apple-releases-ios-11_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342655\" data-ts=\"1522347522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PENN\" target=\"_blank\">PENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342655-penn-national-shareholders-approve-pinnacle-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Penn National shareholders approve Pinnacle merger</a></h4><ul> <li>Shareholders at Penn National Gaming (<a href='https://seekingalpha.com/symbol/PENN' title='Penn National Gaming, Inc.'>PENN</a> <font color='green'>+1.8%</font>) voted to approve the merger with Pinnacle Entertainment (<a href='https://seekingalpha.com/symbol/PNK' title='Pinnacle Entertainment, Inc.'>PNK</a> <font color='green'>+0.7%</font>).</li><li>The merger proposal includes issuing shares to stockholders of Pinnacle       Entertainment</li>     <li>The deal is expected to close the second half of this calendar year.</li>     <li>CEO update on the merger:&nbsp;\"The acquisition of Pinnacle&rsquo;s operations will allow Penn National to       further raise the bar on providing unparalleled entertainment and gaming       experiences for our regional gaming customers while providing long-term       growth opportunities and efficiencies related to our increased scale.       Following the transaction closing, Penn National will enjoy       significantly greater geographic diversity from a combined 41 properties       in 20 jurisdictions, including 15 of the country&rsquo;s top 30 Metropolitan       Statistical Areas. Financially, we expect the transaction to increase       our annual revenue and be immediately accretive to free cash flow per       share, following the planned divestitures of four casinos and the       realization of approximately $100 million in synergies.\"</li><li>Source: <a href=\"https://seekingalpha.com/pr/17116025-penn-national-gaming-shareholders-approve-pinnacle-entertainment-acquisition\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3342655\" data-linked=\"Penn National shareholders approve Pinnacle merger\" data-tweet=\"$PENN $PENN $PNK - Penn National shareholders approve Pinnacle merger https://seekingalpha.com/news/3342655-penn-national-shareholders-approve-pinnacle-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3342655-penn-national-shareholders-approve-pinnacle-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342654\" data-ts=\"1522347385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342654-facebook-trial-over-photo-biometrics-set-for-july\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook trial over photo biometrics set for July</a></h4><ul>   <li>A U.S. district judge has set a trial over Facebook's (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+4.4%</font>) use of biometrics for July in San Francisco.</li>    <li>Judge James Donato directed plaintiffs and the company toward settlement talks ahead of a trial that he's set for July 9, Bloomberg reports.</li>    <li>He wrapped up a hearing without ruling on plaintiff's request for class-action status, to represent millions of users in Illinois; and he told Facebook's lawyers he didn't buy their argument that users of Facebook's photo-tagging feature gave consent through their user agreement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342654\" data-linked=\"Facebook trial over photo biometrics set for July\" data-tweet=\"$FB - Facebook trial over photo biometrics set for July https://seekingalpha.com/news/3342654-facebook-trial-over-photo-biometrics-set-for-july?source=tweet\" data-url=\"https://seekingalpha.com/news/3342654-facebook-trial-over-photo-biometrics-set-for-july\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342653\" data-ts=\"1522347161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342653-amazon-reverses-green-nasdaq-up-2-bonds-continue-to-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon reverses into the green, Nasdaq up 2%, bonds continue to rally</a></h4><ul><li>The president has some frustrations over Amazon, but he's not mulling any actions against the company, says a White House spokesperson. The news has helped spark a reversal in the stock, now<font color='green'> up 1.1%</font>&nbsp;on the session.</li><li>That, in turn, has the Nasdaq&nbsp;<font color='green'>up 2%</font>&nbsp;a couple of hours prior to the end of Q1. The S&amp;P 500 is&nbsp;<font color='green'>higher by 1.6%</font>&nbsp;and the Dow&nbsp;<font color='green'>1.55%</font>.</li><li>The bond market, for now, isn't buying the bounce in stocks, with the 10-year Treasury yield down four basis points on the session to 2.74%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-1.4%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3342653\" data-linked=\"Amazon reverses into the green, Nasdaq up 2%, bonds continue to rally\" data-tweet=\"$TLT $TBT - Amazon reverses into the green, Nasdaq up 2%, bonds continue to rally https://seekingalpha.com/news/3342653-amazon-reverses-green-nasdaq-up-2-bonds-continue-to-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3342653-amazon-reverses-green-nasdaq-up-2-bonds-continue-to-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342651\" data-ts=\"1522346422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNT\" target=\"_blank\">UNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342651-energy-materials-top-5-gainers-losers-of-2-00-pm-03-29-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (03/29/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/UNT' title='Unit Corporation'>UNT</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/JAG' title='Jagged Peak Energy'>JAG</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ECT' title='ECA Marcellus Trust I'>ECT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342651\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (03/29/2018)\" data-tweet=\"$UNT $UNT $PES - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (03/29/2018) https://seekingalpha.com/news/3342651-energy-materials-top-5-gainers-losers-of-2-00-pm-03-29-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342651-energy-materials-top-5-gainers-losers-of-2-00-pm-03-29-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342648\" data-ts=\"1522345483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTCH\" target=\"_blank\">MTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342648-match-group-responds-to-bumble-lawsuit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Match Group responds to Bumble lawsuit</a></h4><ul><li>           Match Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MTCH' title='Match Group, Inc.'>MTCH</a>) <a href=\"https://www.reuters.com/article/us-match-group-bumble/dating-app-bumble-sues-rival-match-group-idUSKBN1H51XG\" target=\"_blank\">responds</a> to the Bumble lawsuit. </li><li> Statement, to Reuters: &ldquo;This lawsuit is a petulant and meritless response to our patent, trademark and trade secret claims. We obviously think their lawsuit has no substance and look forward to proving that in court.&rdquo; </li><li> Match Group shares are&nbsp;<font color='green'>up 3.9%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3342577-bumble-sues-match-group-fraud-trade-secret-theft\" target=\"_blank\">Bumble sues Match Group for fraud and trade secret theft</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342648\" data-linked=\"Match Group responds to Bumble lawsuit\" data-tweet=\"$MTCH - Match Group responds to Bumble lawsuit https://seekingalpha.com/news/3342648-match-group-responds-to-bumble-lawsuit?source=tweet\" data-url=\"https://seekingalpha.com/news/3342648-match-group-responds-to-bumble-lawsuit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342755\" data-ts=\"1522345182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JEC\" target=\"_blank\">JEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342755-significantly-undervalued-jacobs-engineering-upgraded-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Significantly undervalued&#39; Jacobs Engineering upgraded at Deutsche Bank</a></h4><ul>     <li>Jacobs Engineering (<a href='https://seekingalpha.com/symbol/JEC' title='Jacobs Engineering Group Inc.'>JEC</a> <font color='green'>+4.1%</font>) jumps after Deutsche Bank <a href=\"https://thefly.com/thestreet/realmoney/index.php/JECid2706134/JEC-Deutsche-Bank-upgrades-significantly-undervalued-Jacobs-Engineering-to-Buy\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $73 price target, saying the stock is \"significantly undervalued\" and the market is pricing in a near certain probability the CH2M merger integration will fail.</li>     <li>Deutsche Bank believes the concerns are overdone and that the risk of the merger is lower than other E&amp;C deals, as JEC management has a strong execution track record, and sees a path to 65% earnings growth and a doubling of free cash flow over the next three years.</li>          <li>Finally, Deutsche Bank views JEC as a catalyst-rich story with multiple paths to upside - potential 2019 EPS upside, margin and working capital efficiencies, a more aggressive capital return strategy - and is well positioned to gain share in the government services market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342755\" data-linked=\"&#39;Significantly undervalued&#39; Jacobs Engineering upgraded at Deutsche Bank\" data-tweet=\"$JEC $J - &#39;Significantly undervalued&#39; Jacobs Engineering upgraded at Deutsche Bank https://seekingalpha.com/news/3342755-significantly-undervalued-jacobs-engineering-upgraded-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3342755-significantly-undervalued-jacobs-engineering-upgraded-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342643\" data-ts=\"1522343753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFUN\" target=\"_blank\">SFUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342643-fang-holdingsplus-2_2-amid-sunny-2018-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fang Holdings +2.2% amid sunny 2018 profit guidance</a></h4><ul>   <li>Fang Holdings (NYSE:<a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a>) is <font color='green'>up 2.2%</font> after posting <a href=\"https://seekingalpha.com/news/3342457-fang-holdings-misses-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a> that missed expectations after revenues dropped by a third as the company changed business lines, but guided high for 2018 profits.</li>    <li>Non-GAAP operating income was $32.6M; net income attributable to shareholders missed at $15.1M.</li>    <li>The company returned to a full-year profit after two years of net losses, it notes. \"Although Fang is still in its retransformation back to a platform player, it's clear that we are on the right track going forward,\" says Chairman/CEO Vincent Mo.</li>    <li>EBITDA was $35.6M, up from a prior-year $2.4M.</li>    <li>Revenue breakout: E-commerce services, $8.5M (down 91%); Marketing services, $49.6M (up 3.4%); Listing services, $41.8M (up 8.2%); Financial services, $3.65M (up 501%); Other value-added services and other services, $8.65M (up from prior-year deficit of $2.4M).</li>    <li>It's guiding to net income gains of 388%-486% for 2018, to $100M-$120M (above consensus for $96.8M).</li>    <li><a href=\"https://seekingalpha.com/pr/17115304-fang-announces-fourth-quarter-fiscal-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3342643\" data-linked=\"Fang Holdings +2.2% amid sunny 2018 profit guidance\" data-tweet=\"$SFUN - Fang Holdings +2.2% amid sunny 2018 profit guidance https://seekingalpha.com/news/3342643-fang-holdingsplus-2_2-amid-sunny-2018-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3342643-fang-holdingsplus-2_2-amid-sunny-2018-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342642\" data-ts=\"1522343418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342642-midday-gainers-losers-3-29-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (3/29/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/UNT' title='Unit Corporation'>UNT</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/JNP' title='Juniper Pharmaceuticals, Inc.'>JNP</a> <font color='green'>+16%</font>.  <a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='green'>+16%</font>.<a href='https://seekingalpha.com/symbol/SPB' title='Spectrum Brands, Inc.'>SPB</a> <font color='green'>+15%</font>.<a href='https://seekingalpha.com/symbol/HRG' title='HRG Group, Inc.'>HRG</a> <font color='green'>+16%</font>.PSDV <font color='green'>+15%</font>.</li>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>&nbsp;<font color='red'>-50%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a>&nbsp;<font color='red'>-45%</font>. <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>&nbsp;<font color='red'>-44%</font>. <a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a>&nbsp;<font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a>&nbsp;<font color='red'>-22%</font>.  <a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a>&nbsp;<font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a>&nbsp;<font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a>&nbsp;<font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PPSI' title='Pioneer Power Solutions, Inc.'>PPSI</a>&nbsp;<font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a>&nbsp;<font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342642\" data-linked=\"Midday Gainers / Losers (3/29/2018)\" data-tweet=\"$GALT $GALT $MBVXQ - Midday Gainers / Losers (3/29/2018) https://seekingalpha.com/news/3342642-midday-gainers-losers-3-29-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342642-midday-gainers-losers-3-29-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342639\" data-ts=\"1522342820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIPR\" target=\"_blank\">IIPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342639-financials-top-gainers-losers-of-1-00-pm-03-29-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (03/29/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MDLY' title='Medley Management'>MDLY</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342639\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (03/29/2018)\" data-tweet=\"$IIPR $IIPR $JP - Financials - Top Gainers / Losers as of 1:00 PM (03/29/2018) https://seekingalpha.com/news/3342639-financials-top-gainers-losers-of-1-00-pm-03-29-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342639-financials-top-gainers-losers-of-1-00-pm-03-29-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342636\" data-ts=\"1522341783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342636-xpresspaminus-7_4-after-sold-off-operations-drive-wider-2017-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XpresSpa -7.4% after sold-off operations drive wider 2017 loss</a></h4><ul>   <li>XpresSpa (NASDAQ:<a href='https://seekingalpha.com/symbol/XSPA' title='XpresSpa Group'>XSPA</a>) is <font color='red'>7.4% lower</font> after a <a href=\"https://seekingalpha.com/news/3342450-xpresspa-reports-fy-results\" target=\"_blank\">Q4 earnings report</a> where its fiscal-year revenues quadrupled with a pure pivot to wellness, but net loss widened due to discontinued operations.</li>    <li>Revenues grew to $48.8M from $12M, and loss from continuing operations narrowed to $16.1M from a 2016 loss of $19.3M.</li>    <li>Comprehensive loss was $28.5M, including operations at FLI Charge (sold in October) and Group Mobile (sold this month), each classified as discontinued.</li>    <li>In the Wellness segment, revenues rose 10.4% on a comparable basis, with same-store sales growth of 3%.</li>    <li>For Q4, gross profit was $2.4M (a 20.4% margin), and operating loss was $1.2M.</li>    <li>At year-end the company had cash of $6.4M and long-term debt of $6.5M.</li>    <li><a href=\"https://seekingalpha.com/pr/17115283-xpresspa-group-reports-fourth-quarter-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3342636\" data-linked=\"XpresSpa -7.4% after sold-off operations drive wider 2017 loss\" data-tweet=\"$XSPA - XpresSpa -7.4% after sold-off operations drive wider 2017 loss https://seekingalpha.com/news/3342636-xpresspaminus-7_4-after-sold-off-operations-drive-wider-2017-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3342636-xpresspaminus-7_4-after-sold-off-operations-drive-wider-2017-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342635\" data-ts=\"1522341569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GKNCF\" target=\"_blank\">GKNCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342635-melrose-industries-beats-dana-in-takeover-battle-for-gkn\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Melrose Industries beats Dana in takeover battle for GKN</a></h4><ul>     <li>Melrose Industries <a href=\"https://www.reuters.com/article/us-gkn-m-a-melrose-outcome/melrose-wins-uk-engineer-gkn-with-11-billion-hostile-bid-idUSKBN1H52A1\" target=\"_blank\">wins a takeover battle</a> for plane and car parts maker GKN (<a href='https://seekingalpha.com/symbol/GKNCF' title='GKN Plc'>OTC:GKNCF</a>), effectively <a href=\"https://www.wsj.com/articles/melrose-industries-wins-bruising-takeover-battle-for-britains-gkn-1522339171\" target=\"_blank\">ending a $6.1B deal</a> by Dana Corp. (<a href='https://seekingalpha.com/symbol/DAN' title='Dana, Inc.'>DAN</a> <font color='green'>+2.6%</font>) to merge with its U.K. peer's autos division.</li>     <li>The U.K.-based turnaround specialist says 52.4% of GKN shareholders accepted its hostile cash-and-shares offer by the time the deadline for a deal expired at 1200 GMT.</li>     <li>Melrose had offered &pound;1.4B in cash and 1.69 of its own shares for each GKN share and promised to keep the business based and listed in the U.K. for at least five years.</li>     <li>Dana had said it expected its deal with GKN to lower its tax bill by becoming a U.K. company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342635\" data-linked=\"Melrose Industries beats Dana in takeover battle for GKN\" data-tweet=\"$GKNCF $GKNCF $DAN - Melrose Industries beats Dana in takeover battle for GKN https://seekingalpha.com/news/3342635-melrose-industries-beats-dana-in-takeover-battle-for-gkn?source=tweet\" data-url=\"https://seekingalpha.com/news/3342635-melrose-industries-beats-dana-in-takeover-battle-for-gkn\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342632\" data-ts=\"1522340137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOV\" target=\"_blank\">MOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342632-consumer-top-5-gainers-losers-of-12-15-pm-03-29-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:15 PM (03/29/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/SPB' title='Spectrum Brands, Inc.'>SPB</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ENR' title='Energizer Holdings, Inc.'>ENR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342632\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:15 PM (03/29/2018)\" data-tweet=\"$MOV $MOV $SPB - Consumer - Top 5 Gainers / Losers as of 12:15 PM (03/29/2018) https://seekingalpha.com/news/3342632-consumer-top-5-gainers-losers-of-12-15-pm-03-29-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342632-consumer-top-5-gainers-losers-of-12-15-pm-03-29-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342628\" data-ts=\"1522339762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMC\" target=\"_blank\">FMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342628-fmc-corp-sees-q1-fy-2018-earnings-beating-high-end-of-prior-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FMC Corp. sees Q1, FY 2018 earnings beating high end of prior guidance</a></h4><ul>     <li>FMC Corp. (<a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a> <font color='green'>+4.3%</font>) is sharply higher after saying it expects Q1 adjusted EPS to <a href=\"https://seekingalpha.com/pr/17115695-fmc-gives-update-expected-performance-first-quarter-full-year-2018-ahead-scheduled-meeting\" target=\"_blank\">exceed the high end of its prior guidance</a> range of $1.45-$1.59 and FY 2018 adjusted EPS to beat the top end of its prior guidance of $5.20-$5.60.</li><li>FMC says Q1 performance has been driven by stronger  segment earnings; a combination  of strong customer demand and lower achieved operating costs are leading  to higher earnings in agricultural solutions, and continued strong market conditions are sparking the company's lithium unit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342628\" data-linked=\"FMC Corp. sees Q1, FY 2018 earnings beating high end of prior guidance\" data-tweet=\"$FMC - FMC Corp. sees Q1, FY 2018 earnings beating high end of prior guidance https://seekingalpha.com/news/3342628-fmc-corp-sees-q1-fy-2018-earnings-beating-high-end-of-prior-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3342628-fmc-corp-sees-q1-fy-2018-earnings-beating-high-end-of-prior-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342627\" data-ts=\"1522339744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342627-nvidia-ceo-uber-doesnt-use-self-driving-platform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia CEO: Uber doesn&#39;t use our self-driving platform</a></h4><ul><li>        Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) CEO Jensen Huang <a href=\"https://www.cnbc.com/2018/03/29/chipmaker-nvidias-ceo-says-uber-does-not-use-its-self-driving-processing-solution.html\" target=\"_blank\">says</a> Uber (<a href='https://seekingalpha.com/symbol/UBER' title='Uber'>UBER</a>) doesn&rsquo;t use his company&rsquo;s DRIVE self-driving platform architecture.</li><li>                  Uber instead users Nvidia&rsquo;s GPUs and &ldquo;develops its own sensing and drive technology.&rdquo;    </li><li>               Nvidia suspended its own self-driving test program earlier this week after an Uber self-driving vehicle fatally struck a pedestrian.</li><li>               Nvidia later launched a self-driving simulation system.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341938-reuters-nvidia-suspends-self-driving-test-program-uber-fatality\" target=\"_blank\">Reuters: Nvidia suspends self-driving test program after Uber fatality</a> (March 27)</li><li>               Nvidia shares are&nbsp;<font color='green'>up 2.3%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341971-nvidia-launches-self-driving-simulation-system-kubernetes-support\" target=\"_blank\">Nvidia launches self-driving simulation system, Kubernetes support</a> (March 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342210-reuters-uber-cut-back-lidar-self-driving-fleet\" target=\"_blank\">Reuters: Uber cut back on lidar in self-driving fleet</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342627\" data-linked=\"Nvidia CEO: Uber doesn&#39;t use our self-driving platform\" data-tweet=\"$NVDA $NVDA $UBER - Nvidia CEO: Uber doesn&#39;t use our self-driving platform https://seekingalpha.com/news/3342627-nvidia-ceo-uber-doesnt-use-self-driving-platform?source=tweet\" data-url=\"https://seekingalpha.com/news/3342627-nvidia-ceo-uber-doesnt-use-self-driving-platform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342626\" data-ts=\"1522339425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342626-stocks-post-sharp-gains-midday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks post sharp gains at midday</a></h4><ul><li>The averages are looking to close out the quarter on a strong note, with the Dow, S&amp;P 500, and Nasdaq all&nbsp;<font color='green'>higher by more than 1%</font>&nbsp;at the noon hour.</li><li>Helping are nice bounces in roughed-up names - namely Facebook&nbsp;<font color='green'>up 4%</font>&nbsp;and Tesla&nbsp;<font color='green'>up 1.15%.</font>&nbsp;A notable decliner is GE,&nbsp;<font color='red'>down 2%</font>&nbsp;after two days of Buffett-inspired gains.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342626\" data-linked=\"Stocks post sharp gains at midday\" data-tweet=\"Stocks post sharp gains at midday https://seekingalpha.com/news/3342626-stocks-post-sharp-gains-midday?source=tweet\" data-url=\"https://seekingalpha.com/news/3342626-stocks-post-sharp-gains-midday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342619\" data-ts=\"1522338613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342619-accenture-acquires-meredith-digital-agency\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture acquires Meredith digital agency</a></h4><ul><li>        Accenture (NYSE:<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a>) <a href=\"https://seekingalpha.com/pr/17115895-accenture-acquire-mxm-content-powered-digital-marketing-agency\" target=\"_blank\">acquires</a> digital agency Meredith Xcelerated Marketing from Meredith Corporation (NYSE:<a href='https://seekingalpha.com/symbol/MDP' title='Meredith Corporation'>MDP</a>) for undisclosed terms.</li><li>               Meredith Xcelerated clients include Barilla, Kraft Heinz, Lowe&rsquo;s, and Bob Evans Restaurants.&nbsp;</li><li>               Accenture shares are&nbsp;<font color='green'>up 1.7%</font>.&nbsp;</li><li>               Meredith Corporation shares are&nbsp;<font color='green'>up 1.8%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3342619\" data-linked=\"Accenture acquires Meredith digital agency\" data-tweet=\"$ACN $ACN $MDP - Accenture acquires Meredith digital agency https://seekingalpha.com/news/3342619-accenture-acquires-meredith-digital-agency?source=tweet\" data-url=\"https://seekingalpha.com/news/3342619-accenture-acquires-meredith-digital-agency\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342615\" data-ts=\"1522337679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIPR\" target=\"_blank\">IIPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342615-innovative-industrial-is-up-10-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innovative Industrial is up more than 10% after earnings</a></h4><ul><li>The company reports Q4 AFFO of $0.23 per share vs&nbsp;-$0.40 last year.&nbsp;Dividend&nbsp;$0.25 per share.</li><li>Among Q4 events was the raising of $14M in preferred equity.</li><li>In addition, the company acquired a total of three cannabis cultivation and processing facilities, all in a sale-leaseback style transaction.</li><li>Shares of Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a>) are&nbsp;<font color='green'>up</font>&nbsp;<font color='green'>10.8%&nbsp;</font></li><li><a href=\"http://investors.innovativeindustrialproperties.com/\" target=\"_blank\">Conference Call</a>&nbsp;is at 12</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342365-innovative-industrial-properties-ffo-line-beats-revenue\" target=\"_blank\">Innovative Industrial Properties FFO in-line, beats on revenue</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342615\" data-linked=\"Innovative Industrial is up more than 10% after earnings\" data-tweet=\"$IIPR - Innovative Industrial is up more than 10% after earnings https://seekingalpha.com/news/3342615-innovative-industrial-is-up-10-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3342615-innovative-industrial-is-up-10-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342613\" data-ts=\"1522336880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342613-steel-stocks-rise-deutsche-bank-says-solid-fundamentals-not-priced-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel stocks rise as Deutsche Bank says solid fundamentals not priced in</a></h4><ul>     <li>Steel stocks are higher, thanks in part to a <a href=\"https://www.barrons.com/articles/steel-stocks-a-riveting-outlook-1522333532\" target=\"_blank\">bullish outlook</a> from Deutsche Bank, which reiterates Buy recommendations for U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+5.4%</font>), AK&nbsp;Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+4.7%</font>), Nucor (<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+2.5%</font>), Steel Dynamics (<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+2.7%</font>), Commercial Metals (<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+1.6%</font>), Reliant Steel (<a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='green'>+3.2%</font>) and Ryerson Holding (<a href='https://seekingalpha.com/symbol/RYI' title='Ryerson Holding Corp.'>RYI</a> <font color='green'>+2.5%</font>).</li>     <li>Steel stocks have been hurt by tariff exemptions, sending most to the same levels as late last year, but the firm thinks plenty of room remains to be positive on the stocks, which are not pricing in solid fundamentals.</li>     <li>Deutsche Bank believes more upward revisions and stock upgrades will come as companies begin reporting Q1 results and provide updated guidance.</li><li><a href=\"https://seekingalpha.com/news/3342539-u-s-steel-benefit-higher-prices-supply-shortage-analyst-says\" target=\"_blank\">Earlier</a>: U.S. Steel to benefit from higher prices, supply shortage, analyst says (Mar. 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342613\" data-linked=\"Steel stocks rise as Deutsche Bank says solid fundamentals not priced in\" data-tweet=\"$X $X $AKS - Steel stocks rise as Deutsche Bank says solid fundamentals not priced in https://seekingalpha.com/news/3342613-steel-stocks-rise-deutsche-bank-says-solid-fundamentals-not-priced-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3342613-steel-stocks-rise-deutsche-bank-says-solid-fundamentals-not-priced-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342612\" data-ts=\"1522336712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342612-microsoft-announces-major-reorganization-including-ai-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft announces major reorganization including AI focus</a></h4><ul><li>        Microsoft (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) <a href=\"https://www.cnbc.com/2018/03/29/microsoft-reorganizes-splits-company-into-2-divisions.html\" target=\"_blank\">announces a major reorganization</a> to focus one division on experiences and devices and another on cloud and AI platforms.</li><li>               As part of the reorganization, windows and devices group VP Terry Myerson is leaving the company.&nbsp;</li><li>               Rajesh Jha, current product group head, will lead the experiences and devices group.&nbsp;</li><li>               Scott Guthrie, current head of the cloud and enterprise group, will head the cloud and AI division.&nbsp;</li><li>               More appointments: Jason Zander becomes executive VP of Azure with the Windows platform team joining him, Panos Panay becomes chief product officer and devices leader, Joe Belfiore stays as Windows experiences leader, Kudo Tsunoda will stay as new experiences and technology leader, and Brad Anderson will continue leading Windows Enterprise.&nbsp;</li><li>                  Read more about the reorganization and the various job title shifts <a href=\"https://www.cnbc.com/2018/03/29/microsoft-reorganizes-splits-company-into-2-divisions.html\" target=\"_blank\">here</a>.    </li><li>               Microsoft shares are&nbsp;<font color='green'>up 0.7%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3342612\" data-linked=\"Microsoft announces major reorganization including AI focus\" data-tweet=\"$MSFT - Microsoft announces major reorganization including AI focus https://seekingalpha.com/news/3342612-microsoft-announces-major-reorganization-including-ai-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/3342612-microsoft-announces-major-reorganization-including-ai-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342611\" data-ts=\"1522336606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSET\" target=\"_blank\">BSET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342611-post-earnings-slump-for-bassett-furniture\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings slump for Bassett Furniture</a></h4><ul> <li>Bassett Furniture (<a href='https://seekingalpha.com/symbol/BSET' title='Bassett Furniture Industries, Incorporated'>BSET</a> <font color='red'>-8.1%</font>) is down for a second consecutive day after FQ1 results disappointed.</li> <li>The company reported that operating income as a percentage of sales fell sharply to 1.9% from 4.4% a year ago.</li> <li>Management cited startup expenses associated with growth initiatives and rising material costs in the manufacturing segment as factors in the decline in margins.</li> <li>On Wall Street, Stifel Nicolaus lowered its price target on BSET to $33 from $37.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342611\" data-linked=\"Post-earnings slump for Bassett Furniture\" data-tweet=\"$BSET - Post-earnings slump for Bassett Furniture https://seekingalpha.com/news/3342611-post-earnings-slump-for-bassett-furniture?source=tweet\" data-url=\"https://seekingalpha.com/news/3342611-post-earnings-slump-for-bassett-furniture\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342607\" data-ts=\"1522335774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSM\" target=\"_blank\">INSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342607-insmed-files-u-s-marketing-application-for-inhaled-amikacin-for-type-of-lung-disease-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insmed files U.S. marketing application for inhaled amikacin for type of lung disease; shares up 2%</a></h4><ul><li>Insmed (<a href='https://seekingalpha.com/symbol/INSM' title='Insmed, Inc.'>INSM</a> <font color='green'>+1.6%</font>) <a href=\"https://seekingalpha.com/pr/17115384-insmed-submits-new-drug-application-fda-alis-ntm-lung-disease-caused-mac\" target=\"_blank\">submits </a>a New Drug Application &#40;NDA&#41; to the FDA seeking approval for ALIS (amikacin liposome inhalation suspension) for the treatment of adult patients with nontuberculous mycobacterial lung disease caused by <em>Mycobacterium avium</em> complex. There are currently no approved therapies in the U.S. for the condition.</li><li>The company says it expects a six-month review period considering ALIS's Orphan Drug, Breakthrough Therapy and Qualified Infectious Disease Product &#40;QIDP&#41; status. The agency has 60 days to evaluate the filing for completeness before formally accepting it for review.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3293468-insmeds-inhalable-amikacin-successful-late-stage-study-shares-77-percent-premarket\" target=\"_blank\">Insmed's inhalable amikacin successful in late-stage study, shares up 77% premarket</a> (Sept. 5, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342607\" data-linked=\"Insmed files U.S. marketing application for inhaled amikacin for type of lung disease; shares up 2%\" data-tweet=\"$INSM - Insmed files U.S. marketing application for inhaled amikacin for type of lung disease; shares up 2% https://seekingalpha.com/news/3342607-insmed-files-u-s-marketing-application-for-inhaled-amikacin-for-type-of-lung-disease-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3342607-insmed-files-u-s-marketing-application-for-inhaled-amikacin-for-type-of-lung-disease-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342606\" data-ts=\"1522335672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342606-healthcare-top-5-gainers-losers-of-11-00-03-29-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (03/29/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+17%</font>. PSDV <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CDMO' title='Avid Bioservices, Inc.'>CDMO</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='red'>-44%</font>. <a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MYND' title='MYnd Analytics, Inc.'>MYND</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342606\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (03/29/2018)\" data-tweet=\"$AVGR $AVGR $GALT - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (03/29/2018) https://seekingalpha.com/news/3342606-healthcare-top-5-gainers-losers-of-11-00-03-29-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342606-healthcare-top-5-gainers-losers-of-11-00-03-29-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342601\" data-ts=\"1522335043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342601-avinger-up-20-on-first-in-patient-use-of-extended-noseone-version-of-next-gen-atherectomy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avinger up 20% on first-in-patient use of extended noseone version of next-gen atherectomy device</a></h4><ul><li>Nano cap Avinger (<a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+19.8%</font>) is up on a 22x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17115600-avinger-announces-first-patient-use-extended-nosecone-version-next-generation-pantheris\" target=\"_blank\">announcement </a>of the successful treatment of three patients in Germany with the extended nosecone version of its next-generation Pantheris Lumivascular atherectomy system.</li><li>The company says the longer nosecone enhances the plaque removal capacity of the device. It is available for sale in Europe under the current CE Mark for Patheris.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342601\" data-linked=\"Avinger up 20% on first-in-patient use of extended noseone version of next-gen atherectomy device\" data-tweet=\"$AVGR - Avinger up 20% on first-in-patient use of extended noseone version of next-gen atherectomy device https://seekingalpha.com/news/3342601-avinger-up-20-on-first-in-patient-use-of-extended-noseone-version-of-next-gen-atherectomy?source=tweet\" data-url=\"https://seekingalpha.com/news/3342601-avinger-up-20-on-first-in-patient-use-of-extended-noseone-version-of-next-gen-atherectomy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342569\" data-ts=\"1522334872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342569-another-rough-session-for-crypto-brings-bitcoin-below-7_5k\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another rough session for crypto brings Bitcoin below $7.5K</a></h4><ul><li><a href=\"https://www.marketwatch.com/story/bitcoin-plunges-below-7500-whats-driving-the-selloff-2018-03-29\" target=\"_blank\">Bitcoin hit an intraday low below $7,500</a>&nbsp;as technical selling joined with negative news from a widespread crackdown on exchanges by Japanese regulators, and a discussion of potential fees on the Ethereum platform.</li><li>Cryptocurrencies are off across the board, with Bitcoin at $7,405 <font color='red'>down 7.3%&nbsp;</font>in the last 24 hours, Ethereum at $401 <font color='red'>down 11.9%</font>, Bitcoin Cash at $749 <font color='red'>down 14.9%</font>, Ripple at $0.527 <font color='red'>down 8.8%</font>, and Litecoin at $118 <font color='red'>down 13%,&nbsp;</font>according to <a href=\"https://coinmarketcap.com/\" target=\"_blank\">Coinmarketcap.com</a>.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3342569\" data-linked=\"Another rough session for crypto brings Bitcoin below $7.5K\" data-tweet=\"$GBTC $GBTC $COIN - Another rough session for crypto brings Bitcoin below $7.5K https://seekingalpha.com/news/3342569-another-rough-session-for-crypto-brings-bitcoin-below-7_5k?source=tweet\" data-url=\"https://seekingalpha.com/news/3342569-another-rough-session-for-crypto-brings-bitcoin-below-7_5k\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>134&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342599\" data-ts=\"1522334550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342599-sears-takes-stroll-over-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sears takes a stroll over $3</a></h4><ul> <li>Sears Holdings (SHLD) is back over $3 for the first time in over a month as it looks to put together a four-session winning streak.</li> <li>Sears was&nbsp;<font color='green'>up 7.47%</font>&nbsp;to $3.02 at last check, without any major news out of the company.</li> <li>Sears CEO Eddie Lampert opened up to <a href=\"https://www.vanityfair.com/news/2018/03/the-strange-odyssey-of-hedge-fund-king-eddie-lampert-sears-kmart\" target=\"_blank\">Vanity Fair</a> earlier this week in self-appraising interview that covered everything from his kidnapping to the Sears-Kmart marriage. Lampert also discussed the current state of affairs at the company.</li> <li>\"If I didn&rsquo;t believe that this company could be transformed still &mdash; the window is definitely shrinking &mdash; but if I didn&rsquo;t believe that, I would try to take a different path,\" Lampert told the publication.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342599\" data-linked=\"Sears takes a stroll over $3\" data-tweet=\"$SHLDQ - Sears takes a stroll over $3 https://seekingalpha.com/news/3342599-sears-takes-stroll-over-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3342599-sears-takes-stroll-over-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342598\" data-ts=\"1522334214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNPX\" target=\"_blank\">GNPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342598-genprex-prices-ipo-5-trading-commences-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genprex prices IPO at $5, trading commences today</a></h4><ul><li>Gene therapy outfit <a href=\"https://www.genprex.com/\" target=\"_blank\">Genprex </a>(NASDAQ:<a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc'>GNPX</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/17115517-genprex-announces-pricing-initial-public-offering-common-stock\" target=\"_blank\">prices </a>its <a href=\"https://www.sec.gov/Archives/edgar/data/1595248/000119312517342616/d486549d424b3.htm\" target=\"_blank\">IPO </a>of 1.28M common shares at $5 per share. Underwriters over-allotment is an additional 192K shares. Closing date is April 3. Trading kicks off today.</li><li>The Austin, TX-based clinical-stage company develops cancer treatments. Lead candidate is Phase 2-stage Oncoprex for non-small cell lung cancer &#40;NSCLC&#41;.</li><li>Oncoprex is an immunogene therapy consisting of a gene called TUSC2 that is encapsulated in a positively charged lipid nanovesicle. Once injected intravenously, it targets cancer cells which are normally negatively charged. The company says its approach minimizes the uptake of the gene therapy by normal tissue. In studies conducted at MD Anderson, the uptake of TUSC2 in tumor cells was as much as 25x higher than normal cells.</li><li><strong>2017 Financials</strong> (9 mo.)($M): Operating Expenses: 2.6 (-16.1%); Net Loss: (2.6) (+16.1%); Cash Burn: (2.0) (-390.5%).</li></ul><div class=\"tiny-share-widget\" data-id=\"3342598\" data-linked=\"Genprex prices IPO at $5, trading commences today\" data-tweet=\"$GNPX - Genprex prices IPO at $5, trading commences today https://seekingalpha.com/news/3342598-genprex-prices-ipo-5-trading-commences-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3342598-genprex-prices-ipo-5-trading-commences-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342596\" data-ts=\"1522334101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342596-bloomberg-amazon-plans-checking-account-product-for-teens\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Amazon plans checking account product for teens</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) <a href=\"https://www.bloomberg.com/news/articles/2018-03-29/amazon-s-next-challenge-teens-without-the-plastic-to-buy-online?utm_medium=social&amp;cmpid%3D=socialflow-twitter-tech&amp;utm_content=tech&amp;utm_source=twitter&amp;utm_campaign=socialflow-organic\" target=\"_blank\">wants to create a checking account</a> product aimed at teenagers, according to Bloomberg sources.</li><li>               The tech giant is in talks with banks including JPMorgan and Capital One to create the product.&nbsp;</li><li>               Amazon previously launched Amazon Cash, a debit card alternative that let teens drop off money at participating drugstores or retailers. The money would go into an Amazon wallet for use online. But the process isn&rsquo;t as smooth as Amazon would like.&nbsp;</li><li>               Minors typically aren&rsquo;t able to sign up for a bank account without the permission of a parent and the checking account has service charges and overdraft fees. Amazon hopes to offer a better experience.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 2.2%</font>&nbsp;on another rough day of President Trump stories.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342509-president-trump-tweets-amazon-shares-minus-0_4-percent\" target=\"_blank\">President Trump tweets about Amazon; shares -0.4%</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342596\" data-linked=\"Bloomberg: Amazon plans checking account product for teens\" data-tweet=\"$AMZN - Bloomberg: Amazon plans checking account product for teens https://seekingalpha.com/news/3342596-bloomberg-amazon-plans-checking-account-product-for-teens?source=tweet\" data-url=\"https://seekingalpha.com/news/3342596-bloomberg-amazon-plans-checking-account-product-for-teens\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342595\" data-ts=\"1522334058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAAS\" target=\"_blank\">CAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342595-on-china-automitive-systems-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Automitive Systems&#39; Q4</a></h4><ul><li>China Automotive Systems (<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a> <font color='red'>-0.9%</font>)&nbsp;reports net sales declined 3.9% in <a href=\"https://seekingalpha.com/pr/17115235-china-automotive-systems-reports-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Q4</a>, due to the exceptionally strong Chinese auto market in the 4Q16 and the production for new products targeting the Company's North American customers reaching its full capacity.</li><li>Gross margin rate squeezed 310 bps to 11.5%,&nbsp;primarily due to the decrease in net sales and change of product mix.</li><li>Selling expense rate grew 140 bps to 4.7%.</li><li>The company expects FY2018 revenue to be $510M.</li><li>Mr.&nbsp;Qizhou Wu, chief executive officer of CAAS, commented, \"Our growth in 2017 was led by higher sales of our new advanced hydraulic products into the North American market and higher sales of hydraulic products for the commercial vehicle market in&nbsp;China. Our sales to&nbsp;North America&nbsp;grew by 51.4% and accounted for 16.9% of total sales in 2017. Truck sales in&nbsp;Chinagrew by 16.9% in&nbsp;China, led by record sales of 1.1 million units of heavy-duty trucks. With our large and broad line of steering products, we are well positioned to take advantage of growth opportunities in a number of automotive segments.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3342595\" data-linked=\"More on China Automitive Systems&#39; Q4\" data-tweet=\"$CAAS - More on China Automitive Systems&#39; Q4 https://seekingalpha.com/news/3342595-on-china-automitive-systems-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3342595-on-china-automitive-systems-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342588\" data-ts=\"1522333177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSAT\" target=\"_blank\">VSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342588-viasatminus-4_7-barclays-cuts-to-underweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViaSat -4.7% as Barclays cuts to Underweight</a></h4><ul>   <li>ViaSat (NASDAQ:<a href='https://seekingalpha.com/symbol/VSAT' title='Viasat, Inc.'>VSAT</a>) is <font color='red'>4.7% lower</font> after a cut to Underweight by Barclays this morning.</li>    <li>The firm trimmed its price target to $60 from $75, implying 5.5% further downside from current pricing.</li>    <li>Shares are <font color='green'>6.1% higher</font> over the past 12 months, but a 2018 decline has them <font color='red'>down 11%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342588\" data-linked=\"ViaSat -4.7% as Barclays cuts to Underweight\" data-tweet=\"$VSAT - ViaSat -4.7% as Barclays cuts to Underweight https://seekingalpha.com/news/3342588-viasatminus-4_7-barclays-cuts-to-underweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3342588-viasatminus-4_7-barclays-cuts-to-underweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342587\" data-ts=\"1522332466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGR\" target=\"_blank\">RGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342587-firearm-stocks-on-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Firearm stocks on the rise</a></h4><ul> <li>Firearms stocks are higher today. The bump comes a day after President Trump <a href=\"https://twitter.com/realDonaldTrump/status/978932860307505153\" target=\"_blank\">tweeted</a> that the second amendment will never be repealed.</li> <li>The POTUS shot seems to be a reaction to an <a href=\"https://www.nytimes.com/2018/03/27/opinion/john-paul-stevens-repeal-second-amendment.html\" target=\"_blank\">editorial</a> by former Supreme Court Justice John Paul Stevens as the focus on the legislative front has been on assault weapons and gun show loopholes.</li> <li>Sturm, Ruger &amp; Company (<a href='https://seekingalpha.com/symbol/RGR' title='Sturm, Ruger & Company Inc.'>RGR</a> <font color='green'>+3.7%</font>), American Outdoor Brands (<a href='https://seekingalpha.com/symbol/AOBC' title='American Outdoor Brands Corporation'>AOBC</a> <font color='green'>+3.6%</font>) and Vista Outdoors (<a href='https://seekingalpha.com/symbol/VSTO' title='Vista Outdoor'>VSTO</a> <font color='green'>+1.7%</font>) are all higher on the day.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3342587\" data-linked=\"Firearm stocks on the rise\" data-tweet=\"$RGR $RGR $AOBC - Firearm stocks on the rise https://seekingalpha.com/news/3342587-firearm-stocks-on-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3342587-firearm-stocks-on-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342580\" data-ts=\"1522331965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESRX\" target=\"_blank\">ESRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342580-credit-suisse-defends-express-scripts-after-18-retracement-since-cigna-deal-announced-on\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse defends Express Scripts after 18% retracement since Cigna deal announced on March 8</a></h4><ul><li>Credit Suisse's Erin Wilson calls the selloff in Express Scripts (<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='green'>+0.1%</font>) \"egregious\" since shares are now exchanging hands at levels seen before the tie-up with Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color='red'>-0.6%</font>)&nbsp;was announced a few weeks ago.</li><li>She rates ESRX Outperform citing the high probability that regulators will sign off on the merger. In the event of a thumbs down, she values the company at $85 (21% upside) per share on a standalone basis implying a 10.6x multiple of 2019 non-GAAP EBITDA.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337401-cigna-buys-express-scripts-67b\" target=\"_blank\">Cigna buys Express Scripts for $67B</a> (March 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342580\" data-linked=\"Credit Suisse defends Express Scripts after 18% retracement since Cigna deal announced on March 8\" data-tweet=\"$ESRX $ESRX $CI - Credit Suisse defends Express Scripts after 18% retracement since Cigna deal announced on March 8 https://seekingalpha.com/news/3342580-credit-suisse-defends-express-scripts-after-18-retracement-since-cigna-deal-announced-on?source=tweet\" data-url=\"https://seekingalpha.com/news/3342580-credit-suisse-defends-express-scripts-after-18-retracement-since-cigna-deal-announced-on\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342577\" data-ts=\"1522331270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTCH\" target=\"_blank\">MTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342577-bumble-sues-match-group-for-fraud-and-trade-secret-theft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bumble sues Match Group for fraud and trade secret theft</a></h4><ul><li>        Dating app Bumble <a href=\"https://www.reuters.com/article/us-match-group-bumble/dating-app-bumble-sues-rival-match-group-idUSKBN1H51XG\" target=\"_blank\">sues</a> rival Match Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MTCH' title='Match Group, Inc.'>MTCH</a>) for fraud and trade secret theft.</li><li>               Bumble seeks $400M from the owner of Tinder, saying Match used deceptive means to obtain sensitive information and has disparaged Bumble.&nbsp;</li><li>Match recently sued Bumble for IP infringement. But the sour relationship traces back to failed buyout discussions.&nbsp;</li><li>               Match Group shares are&nbsp;<font color='green'>up 0.5%</font>&nbsp;to $43.39.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3340449-match-group-sues-bumble-patent-infringement-bumble-responds\" target=\"_blank\">Match Group sues Bumble for patent infringement, Bumble responds</a> (March 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342577\" data-linked=\"Bumble sues Match Group for fraud and trade secret theft\" data-tweet=\"$MTCH - Bumble sues Match Group for fraud and trade secret theft https://seekingalpha.com/news/3342577-bumble-sues-match-group-for-fraud-and-trade-secret-theft?source=tweet\" data-url=\"https://seekingalpha.com/news/3342577-bumble-sues-match-group-for-fraud-and-trade-secret-theft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342575\" data-ts=\"1522331193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADS\" target=\"_blank\">ADS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342575-alliance-data-systems-down-2_7-on-bearish-ows-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Data Systems down 2.7% on bearish OWS report</a></h4><ul><li>Off Wall Street takes note of rising competition in the credit card business as being a headwind for Alliance Data Systems (<a href='https://seekingalpha.com/symbol/ADS' title='Alliance Data Systems Corporation'>ADS</a> <font color='red'>-2.7%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3342575\" data-linked=\"Alliance Data Systems down 2.7% on bearish OWS report\" data-tweet=\"$ADS - Alliance Data Systems down 2.7% on bearish OWS report https://seekingalpha.com/news/3342575-alliance-data-systems-down-2_7-on-bearish-ows-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3342575-alliance-data-systems-down-2_7-on-bearish-ows-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342573\" data-ts=\"1522331005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342573-zosano-prices-stock-offering-5-shares-down-44\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano prices stock offering at $5; shares down 44%</a></h4><ul><li>Nano cap Zosano Pharma (<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='red'>-43.5%</font>) <a href=\"https://seekingalpha.com/pr/17115612-zosano-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 10M shares of common stock at $5 per share. Underwriters over-allotment is an additional 1.5M shares. Closing date is April 3.</li><li>Yesterday's close was $9.17.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3334250-zosano-big-news-scarce-shares-ahead-95-percent\" target=\"_blank\">Zosano up big but news scarce; shares ahead 95%</a> (Feb. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342573\" data-linked=\"Zosano prices stock offering at $5; shares down 44%\" data-tweet=\"$ZSAN - Zosano prices stock offering at $5; shares down 44% https://seekingalpha.com/news/3342573-zosano-prices-stock-offering-5-shares-down-44?source=tweet\" data-url=\"https://seekingalpha.com/news/3342573-zosano-prices-stock-offering-5-shares-down-44\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342558\" data-ts=\"1522329853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YNDX\" target=\"_blank\">YNDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342558-yandexplus-2_2-citi-boosts-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yandex +2.2% as Citi boosts to Buy</a></h4><ul>   <li>Search engine Yandex (NASDAQ:<a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a>) is <font color='green'>up 2.2%</font> premarket as Citi upgrades it to Buy from Neutral, as a switch in valuation methods suggests a higher price point.</li>    <li>Switching from pure multiples to a look at the sum of the parts, the firm values Yandex.Taxi at 1 time fiscal 2019 gross bookings, and the rest of the business at 15 times fiscal 2019 EBITDA. (h/t Bloomberg)</li>    <li>Russia's ad market kept getting better last year and Yandex kept building market share in it, on desktop and mobile, analyst Brady Martin notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342558\" data-linked=\"Yandex +2.2% as Citi boosts to Buy\" data-tweet=\"$YNDX - Yandex +2.2% as Citi boosts to Buy https://seekingalpha.com/news/3342558-yandexplus-2_2-citi-boosts-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3342558-yandexplus-2_2-citi-boosts-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342557\" data-ts=\"1522329425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAMP\" target=\"_blank\">RAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342557-acxiomminus-10_7-seeing-25m-hit-from-facebook-data-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acxiom -10.7%, seeing $25M hit from Facebook data changes</a></h4><ul>   <li>Acxiom (NYSE:<a href='https://seekingalpha.com/symbol/ACXM' title='LiveRamp Holdings, Inc.'>ACXM</a>) is <font color='red'>10.7% lower</font> premarket after <a href=\"https://seekingalpha.com/news/3342386-another-privacy-move-facebook-ending-partner-categories\" target=\"_blank\">Facebook's announcement late yesterday</a> that it would phase out Partner Categories, the use of third-party data from firms like Acxiom as a targeting source for advertisers.</li>    <li>Overnight, the company <a href=\"https://seekingalpha.com/pr/17115137-acxiom-announces-change-facebook-relationship\" target=\"_blank\">said in a statement</a> that while it won't impact 2018 guidance, it expects a hit to 2019 total revenue and profitability of as much as $25M.</li>    <li>It still expects its LiveRamp segment to grow at least 30% Y/Y.</li>    <li>&ldquo;Today, more than ever, it is important for businesses to be able to rely upon companies that understand the critical importance of ethically sourced data and strong data governance. These are among Acxiom&rsquo;s core strengths,&rdquo; says CEO Scott Howe. &ldquo;It will always be true that the ethical use of data creates tremendous value for both businesses and consumers.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342557\" data-linked=\"Acxiom -10.7%, seeing $25M hit from Facebook data changes\" data-tweet=\"$RAMP - Acxiom -10.7%, seeing $25M hit from Facebook data changes https://seekingalpha.com/news/3342557-acxiomminus-10_7-seeing-25m-hit-from-facebook-data-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/3342557-acxiomminus-10_7-seeing-25m-hit-from-facebook-data-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342541\" data-ts=\"1522329356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342541-square-recovering-jeffries-seeing-24-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Square recovering with Jeffries seeing 24% upside</a></h4><ul><li>Jefferies analyst Ramsey El-Assal<a href=\"https://www.marketwatch.com/story/square-services-business-could-make-up-half-of-revenue-by-2022-says-analyst-2018-03-29\" target=\"_blank\"> reiterates the company's positives</a> and highlights that the \"subscription and services\" offerings are a key growth driver.</li><li>Products like instant deposits, food delivery, and small-business loans are a quarter of total revenues today, but will have a larger share in the next 5 years.</li><li>\"Our thesis is that as subscription and services becomes a larger part of the overall business, the company should carry a higher multiple,\" writes El-Assal.</li><li>With a $60 price target, and a Buy rating, El-Assal sees the recent pullback as a great buying opportunity.</li><li>Square Inc. (NYSE:<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>) is<font color='green'> up 2.25%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342541\" data-linked=\"Square recovering with Jeffries seeing 24% upside\" data-tweet=\"$SQ - Square recovering with Jeffries seeing 24% upside https://seekingalpha.com/news/3342541-square-recovering-jeffries-seeing-24-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3342541-square-recovering-jeffries-seeing-24-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342551\" data-ts=\"1522329107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342551-premarket-losers-of-9-05-3-29-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (3/29/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>&nbsp;<font color='red'>-45%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3342465-zosano-pharma-readies-stock-offering-shares-25-percent-premarket\" target=\"_blank\">declaring</a> its prospectus for a 10M-share&nbsp;stock offering&nbsp;effective.</li><li><a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3342316-gamestop-beats-0_05-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/EDGE' title='Edge Therapeutics'>EDGE</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3342551\" data-linked=\"Premarket Losers as of 9:05 am (3/29/2018)\" data-tweet=\"$ZSAN $ZSAN $GME - Premarket Losers as of 9:05 am (3/29/2018) https://seekingalpha.com/news/3342551-premarket-losers-of-9-05-3-29-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342551-premarket-losers-of-9-05-3-29-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342546\" data-ts=\"1522328785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FATE\" target=\"_blank\">FATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342546-fate-therapeutics-fate-nk100-shows-encouraging-action-in-early-stage-ovarian-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fate Therapeutics&#39; FATE-NK100 shows encouraging action in early-stage ovarian cancer study; shares ahead 5% premarket</a></h4><ul><li>Fate Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17115402-fate-therapeutics-announces-initial-clinical-data-fate-nk100-recurrent-ovarian-cancer-innate\" target=\"_blank\">announcement </a>of positive preliminary results from a Phase 1 clinical trial evaluating lead immuno-oncology candidate FATE-NK100 in patients with platinum-resistant ovarian cancer.</li><li>In two patients treated to date, no dose-limiting toxicities were observed. The second subject, who had received five prior lines of therapy, showed stable cancer with evidence of tumor reduction after a single intraperitoneal (into the body cavity) infusion.</li><li>The enrollment target is 10 at the highest dose level.</li><li><a href=\"http://fatetherapeutics.com/pipeline/immuno-oncology-candidates/fate-nk100/\" target=\"_blank\">FATE-NK100</a>&nbsp;is a donor-derived adaptive memory natural killer &#40;NK&#41; cell therapy. It is produced via a seven-day manufacturing process during which NK cells sourced from a healthy donor are activated outside of the body with certain modulators.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342546\" data-linked=\"Fate Therapeutics&#39; FATE-NK100 shows encouraging action in early-stage ovarian cancer study; shares ahead 5% premarket\" data-tweet=\"$FATE - Fate Therapeutics&#39; FATE-NK100 shows encouraging action in early-stage ovarian cancer study; shares ahead 5% premarket https://seekingalpha.com/news/3342546-fate-therapeutics-fate-nk100-shows-encouraging-action-in-early-stage-ovarian-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3342546-fate-therapeutics-fate-nk100-shows-encouraging-action-in-early-stage-ovarian-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342539\" data-ts=\"1522328084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342539-u-s-steel-to-benefit-from-higher-prices-supply-shortage-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel to benefit from higher prices, supply shortage, analyst says</a></h4><ul>     <li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>)&nbsp;<font color='green'>+2%</font> premarket after Longbow analyst Chris Olin says the company's tubular segment could benefit from new data that shows both domestic mill shipments and market prices trending slightly above expectations.</li>     <li>Olin says the oil country tubular goods distributor&rsquo;s index showed channel expectations at the highest since early 2017, \"which should support positive industry momentum for the rest of the year.\"</li>     <li>Underlying energy tubular consumption appears to be up 75% Y/Y, while the spot price for welded products is up 21% Y/Y, the analyst says; among distributors, 35% reported supply shortages in January and 90% expected higher mill prices over the next few months.</li>     <li>Other potentially related tickers include <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a>.</li>     <li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342539\" data-linked=\"U.S. Steel to benefit from higher prices, supply shortage, analyst says\" data-tweet=\"$X $X $SLX - U.S. Steel to benefit from higher prices, supply shortage, analyst says https://seekingalpha.com/news/3342539-u-s-steel-to-benefit-from-higher-prices-supply-shortage-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3342539-u-s-steel-to-benefit-from-higher-prices-supply-shortage-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342536\" data-ts=\"1522327964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FINL\" target=\"_blank\">FINL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342536-store-sales-disappoint-finish-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Same-store sales disappoint at Finish Line</a></h4><ul> <li>Finish Line (NASDAQ:<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a>) trades lower after reporting same-store sales plunged 7.9% in <a href=\"https://seekingalpha.com/pr/17115518-finish-line-reports-fourth-quarter-fiscal-2018-full-year-results\" target=\"_blank\">FQ4</a> to miss the consensus estimate for a 5.9% decline.</li> <li>A high point from the report is the 8.5% comp delivered by the Finish Line Macy's business.</li> <li>Gross profit rose to 31.5% of sales vs. 29.1% a year ago, while operating income fell to 2.0% of sales vs. 3.6% a year ago. SG&amp;A expenses rose 140 bps to 24.5% of sales.</li> <li>CEO update: \"While we anticipated that our business would be under pressure during the fourth quarter due to a difficult selling environment for athletic footwear, sales ended up being down more than we forecasted... Despite the top-line headwinds, we worked hard on tightly controlling costs and managing inventories to deliver adjusted earnings per share for the fourth quarter at the high-end of our most recent guidance range of $0.58 to $0.59.\"</li> <li>Finish Line ended the quarter with 556 stores, compared to 573 stores a year ago, after opening 11 stores and closing one during the quarter.</li> <li>FINL <font color='red'>-1.66%</font> premarket to $13.66.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342536\" data-linked=\"Same-store sales disappoint at Finish Line\" data-tweet=\"$FINL - Same-store sales disappoint at Finish Line https://seekingalpha.com/news/3342536-store-sales-disappoint-finish-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3342536-store-sales-disappoint-finish-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342535\" data-ts=\"1522327954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDUS\" target=\"_blank\">RDUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342535-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Radius Health (NASDAQ:<a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a>) initiated with Outperform rating and $53 (54% upside) price target at Leerink. Shares up&nbsp;<font color='green'>3%</font>&nbsp;premarket.</li><li>Compugen (NASDAQ:<a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a>) initiated with Outperform rating and $9 (125% upside) price target at Oppenheimer. Shares up&nbsp;<font color='green'>6%</font>&nbsp;premarket.</li><li>Miragen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) initiated with Buy rating and $14 (105% upside) price target at Jefferies. Shares up&nbsp;<font color='green'>14%</font>&nbsp;premarket.</li><li>Nuvectra (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) initiated with Buy rating and $19 (43% upside) price target at SunTrust. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>Theravance Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/TBPH' title='Theravance Biopharma, Inc.'>TBPH</a>) resumed with Overweight rating and $45 (92% upside) price target at Piper Jaffray.</li><li>Global Medical REIT (NYSEMKT:<a href='https://seekingalpha.com/symbol/GMRE' title='Global Medical REIT, Inc.'>GMRE</a>) upgraded to Buy at DA Davidson. Shares up&nbsp;<font color='green'>4%&nbsp;</font>premarket.</li><li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) upgraded to Buy at Seaport Global Securities. Shares up&nbsp;<font color='green'>7%&nbsp;</font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342535\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$RDUS $RDUS $CGEN - Premarket analyst action - healthcare https://seekingalpha.com/news/3342535-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3342535-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342532\" data-ts=\"1522327731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342532-akamai-tech-resumed-equal-weight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai Tech resumed at Equal Weight</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Resumes+Akamai+Technologies+%28AKAM%29+at+Equalweight/13997347.html\" target=\"_blank\">resumes</a> Akamai Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) with an Equal Weight rating and $75 price target, a 7% upside to yesterday&rsquo;s close.</li><li>               Analyst Keith Weiss cites survey data showing &ldquo;better defensibility with existing customers and strong Security positioning&rdquo; along with improving margins.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337479-akamai-tech-elliott-collab-margin-expansion-plans\" target=\"_blank\">Akamai Tech, Elliott collab on margin expansion plans</a> (March 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342532\" data-linked=\"Akamai Tech resumed at Equal Weight\" data-tweet=\"$AKAM - Akamai Tech resumed at Equal Weight https://seekingalpha.com/news/3342532-akamai-tech-resumed-equal-weight?source=tweet\" data-url=\"https://seekingalpha.com/news/3342532-akamai-tech-resumed-equal-weight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342530\" data-ts=\"1522327435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342530-overstock-com-said-to-be-pulling-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock.com said to be pulling share offering</a></h4><ul> <li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) is now <font color='green'>up 7.44%</font> in premarket trading.</li> <li>Sources tell StreetInsider.com that the company's 4M share offering was <a href=\"https://www.streetinsider.com/Equity+Offerings/Overstock.com+%28OSTK%29+4+million+share+offering+cancelled+%22due+to+market+conditions%22+-+source/13998100.html\" target=\"_blank\">cancelled</a> due to market conditions.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3342483-overstock-com-perky-early-trading\" target=\"_blank\">Overstock.com perky in early trading</a> (March 29)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3342530\" data-linked=\"Overstock.com said to be pulling share offering\" data-tweet=\"$OSTK - Overstock.com said to be pulling share offering https://seekingalpha.com/news/3342530-overstock-com-said-to-be-pulling-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3342530-overstock-com-said-to-be-pulling-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342528\" data-ts=\"1522327366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342528-catalyst-pharma-refiles-u-s-marketing-application-for-firdapse-for-lems-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharma refiles U.S. marketing application for Firdapse for LEMS; shares up 2% premarket</a></h4><ul><li>Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <a href=\"https://seekingalpha.com/pr/17115474-catalyst-pharmaceuticals-announces-submission-new-drug-application-firdapse-treatment-lambert\" target=\"_blank\">resubmits</a> its U.S. marketing application seeking approval for Firdapse (amifampridine) for the treatment of Lambert-Eaton myasthenic syndrome &#40;LEMS&#41;, a rare autoimmune disorder characterized by muscle weakness in the limbs.</li><li>The company says the filing addresses the two issues raised in the FDA's Refusal to File letter issued in February 2016 in response to the first submission.</li><li><a href=\"http://catalystpharma.com/pdf/CPP14005_ANAPoster_RD19M.pdf\" target=\"_blank\">Amifampridine</a>&nbsp;enhances neuromuscular transmission by blocking the potassium channel. This causes depolarization of the presynaptic membranes which opens the calcium channel thereby enabling muscle fibers to contract.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3114086-fda-rejects-catalyst-pharmas-firdapse-nda-shares-slump-38-percent\" target=\"_blank\">FDA rejects Catalyst Pharma's Firdapse NDA; shares slump 38%</a> (Feb. 17, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342528\" data-linked=\"Catalyst Pharma refiles U.S. marketing application for Firdapse for LEMS; shares up 2% premarket\" data-tweet=\"$CPRX - Catalyst Pharma refiles U.S. marketing application for Firdapse for LEMS; shares up 2% premarket https://seekingalpha.com/news/3342528-catalyst-pharma-refiles-u-s-marketing-application-for-firdapse-for-lems-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3342528-catalyst-pharma-refiles-u-s-marketing-application-for-firdapse-for-lems-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342511\" data-ts=\"1522326582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342511-wedbush-loses-confidence-in-starbucks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush loses confidence in Starbucks</a></h4><ul> <li>Wedbush lowers Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) to a Neutral rating after having the coffee chain set at Outperform.</li> <li>The analyst team says it has lost confidence that Starbucks has the necessary drivers to generate high comparable-store sales growth again. Analyst Nick Setyan also points to underwhelming channel checks on U.S. same-store sales growth for the current quarter.</li> <li>Shares of Starbucks are <font color='red'>down 1.12%</font> in premarket trading to $57.25.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3342511\" data-linked=\"Wedbush loses confidence in Starbucks\" data-tweet=\"$SBUX - Wedbush loses confidence in Starbucks https://seekingalpha.com/news/3342511-wedbush-loses-confidence-in-starbucks?source=tweet\" data-url=\"https://seekingalpha.com/news/3342511-wedbush-loses-confidence-in-starbucks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342510\" data-ts=\"1522326489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342510-sorrento-lists-key-milestones-for-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento lists key milestones for 2018</a></h4><ul><li>In a <a href=\"https://seekingalpha.com/pr/17115095-sorrento-therapeutics-chairman-ceo-update-stockholders\" target=\"_blank\">letter to stockholders</a>, Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) Chairman &amp; CEO Dr. Henry Li lists the company's accomplishments so far this year and key expected milestones for the remainder of 2018.</li><li>INDs accepted in China and South Korea for two partnered PD-L1 antibodies.</li><li>ZTlido (topical lidocaine system) approved in the U.S.</li><li>IND submitted for CD38 CAR T candidate.</li><li>First cohort treated in epidural RTX (resiniferatoxin) study for intractable cancer pain.</li><li><strong>Key milestones for the remainder of the year:</strong></li><li>Launch Phase 1 study of CD38 CAR T in relapsed/refractory multiple myeloma in H1 (with partner Celularity).</li><li>File IND for RTX for intra-articular osteoarthritis pain and launch clinical trial in H1.</li><li>Launch clinical trial of Seprehvir and CEA CAR T in solid tumors in H2.</li><li>Launch Phase 1b study of CEA CAR T in liver metastasis of primary solid tumors in H2.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342510\" data-linked=\"Sorrento lists key milestones for 2018\" data-tweet=\"$SRNE - Sorrento lists key milestones for 2018 https://seekingalpha.com/news/3342510-sorrento-lists-key-milestones-for-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3342510-sorrento-lists-key-milestones-for-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342509\" data-ts=\"1522326356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342509-president-trump-tweets-amazon-sharesminus-0_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">President Trump tweets about Amazon; shares -0.4%</a></h4><ul><li>        President Trump <a href=\"https://twitter.com/realDonaldTrump/status/979326715272065024\" target=\"_blank\">tweets</a> about Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) this morning.</li><li>               Tweet: &ldquo;I have stated my concerns with Amazon long before the Election. Unlike others, they pay little or no taxes to state &amp; local governments, use our Postal System as their Delivery Boy (causing tremendous loss to the U.S.), and are putting many thousands of retailers out of business!&rdquo; &nbsp;&nbsp;</li><li>               Amazon shares closed yesterday&nbsp;<font color='red'>down 4.4%</font>&nbsp;after an Axios report that Trump is more concerned with regulating Amazon than Facebook.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 0.4%</font>&nbsp;premarket.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342157-axios-trump-concerned-amazon-facebook\" target=\"_blank\">Axios: Trump more concerned with Amazon than Facebook</a> (March 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342253-reuters-white-house-says-specific-policy-changes-amazon-right-now\" target=\"_blank\">Reuters: White House says no specific policy changes for Amazon right now</a> (March 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342289-analyst-says-panic-potential-trump-amazon-collision-course\" target=\"_blank\">Analyst says not to panic about potential Trump, Amazon \"collision course\"</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342509\" data-linked=\"President Trump tweets about Amazon; shares -0.4%\" data-tweet=\"$AMZN - President Trump tweets about Amazon; shares -0.4% https://seekingalpha.com/news/3342509-president-trump-tweets-amazon-sharesminus-0_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3342509-president-trump-tweets-amazon-sharesminus-0_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>144&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342507\" data-ts=\"1522326152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QQQ\" target=\"_blank\">QQQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342507-trump-tweet-takes-bite-out-of-futures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump tweet takes bite out of futures</a></h4><ul><li>The president <a href=\"https://twitter.com/realDonaldTrump/status/979326715272065024\" target=\"_blank\">minutes ago went after </a>Amazon, arguing the company pays little in the way of state and local taxes, and uses the postal system as its delivery boy - causing big losses to taxpayers.</li><li>The tweet knocked about $30 per share off of Amazon's premarket gain (it's now modestly in the red for the session), and about 30 points off the <a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>'s (which still remain&nbsp;<font color='green'>up 0.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3342507\" data-linked=\"Trump tweet takes bite out of futures\" data-tweet=\"$QQQ - Trump tweet takes bite out of futures https://seekingalpha.com/news/3342507-trump-tweet-takes-bite-out-of-futures?source=tweet\" data-url=\"https://seekingalpha.com/news/3342507-trump-tweet-takes-bite-out-of-futures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342504\" data-ts=\"1522325805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKG\" target=\"_blank\">AKG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342504-gold-fields-asanko-gold-to-enter-ghana-joint-venture\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields, Asanko Gold to enter Ghana joint venture</a></h4><ul>     <li>Asanko Gold (NYSEMKT:<a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a>) <font color='green'>+13.6%</font> premarket after South Africa&rsquo;s Gold Fields (NYSE:<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a>) <a href=\"https://seekingalpha.com/pr/17115190-asanko-gold-receive-us-185-million-gold-fields-50-percent-joint-venture-interest-us-17_6\" target=\"_blank\">agrees to acquire</a> a 50% share of its Ghana mining subsidiary in a $202.6M deal.</li>     <li>AKG says it will receive $185M from GFI for its 50% joint venture interest plus $17.6M for a 9.9% shareholding interest in the company to purchase ~22.35M shares at ~$0.79 each; the government of Ghana will continue to hold a free-carried 10% interest.</li>     <li>AKG's guidance for the Ghana mine during 2019-23 is average annual production of 253K oz. at all-in sustaining costs of $860/oz., with a life-of-mine of at least 15 years.</li>     <li>GFI <font color='red'>-1.5%</font> premarket as <a href=\"https://www.reuters.com/article/us-gold-fields-m-a-asanko-gold/south-africas-gold-fields-ties-up-with-canadas-asanko-in-ghana-idUSKBN1H515X\" target=\"_blank\">investors question</a> whether the African JV will make a return any time soon.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342504\" data-linked=\"Gold Fields, Asanko Gold to enter Ghana joint venture\" data-tweet=\"$AKG $AKG $GFI - Gold Fields, Asanko Gold to enter Ghana joint venture https://seekingalpha.com/news/3342504-gold-fields-asanko-gold-to-enter-ghana-joint-venture?source=tweet\" data-url=\"https://seekingalpha.com/news/3342504-gold-fields-asanko-gold-to-enter-ghana-joint-venture\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342502\" data-ts=\"1522325764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342502-baml-issues-street-low-price-target-on-gamestop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML issues Street-low price target on GameStop</a></h4><ul> <li>Bank of America Merrill Lynch downgrades GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) after digesting the company's Q4 report that included part of the holiday period.</li> <li>\"2018 will be another tough year,\" warns BAML analyst Curtis Nagle. Concerns over GameStop hitting its own full-year guidance were expressed by Nagle in his note to clients.</li> <li>The firm lowers GameStop to an Underperform rating from Neutral and drops the price target to a Street-low&nbsp;<a href=\"https://www.streetinsider.com/Analyst+Comments/BofAMerrill+Lynch+Downgrades+GameStop+%28GME%29+to+Underperform/13997748.html\" target=\"_blank\">$11</a>.</li> <li>Shares of GameStop are <font color='red'>down 2.33%</font> to $13.82 in premarket action. The 52-week low on GME is $13.49.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342319-store-sales-impress-gamestop\" target=\"_blank\">Same-store sales impress at GameStop</a> (March 28)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342502\" data-linked=\"BAML issues Street-low price target on GameStop\" data-tweet=\"$GME - BAML issues Street-low price target on GameStop https://seekingalpha.com/news/3342502-baml-issues-street-low-price-target-on-gamestop?source=tweet\" data-url=\"https://seekingalpha.com/news/3342502-baml-issues-street-low-price-target-on-gamestop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342500\" data-ts=\"1522325649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVFY\" target=\"_blank\">NVFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342500-nova-lifestyle-higher-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nova Lifestyle higher post Q4 results</a></h4><ul><li>Nova Lifestyle (NASDAQ:<a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a>) reports revenue growth of 79.3% in <a href=\"https://seekingalpha.com/pr/17115344-nova-lifestyle-reports-outstanding-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Q4</a>.</li><li>Gross margin rate improved 900 bps to 23.4%, due to increased sales from uniquely designed, premium items.</li><li>SG&amp;A expense rate leveraged 90 bps to 4%.</li><li>Net income was $1.46M for the quarter vs. net loss of $1.48M year ago.</li><li>The company expects expects robust sales and significant earnings growth in FY2018.</li><li>NVFY&nbsp;<font color='green'>+9.31%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342500\" data-linked=\"Nova Lifestyle higher post Q4 results\" data-tweet=\"$NVFY - Nova Lifestyle higher post Q4 results https://seekingalpha.com/news/3342500-nova-lifestyle-higher-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3342500-nova-lifestyle-higher-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342482\" data-ts=\"1522324757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342482-heron-therapeutics-down-4-premarket-on-pricing-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron Therapeutics down 4% premarket on pricing common stock offering</a></h4><ul> <li>Heron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>) <a href=\"https://seekingalpha.com/pr/17115110-heron-therapeutics-announces-pricing-underwritten-public-offering-common-stock\" target=\"_blank\">prices</a> its public       offering of 6M shares of common stock at a price of       $26.00 per share for the gross&nbsp; proceeds of $156M.</li><li>Underwriters over-allotment is an additional&nbsp;900,000 shares.</li>     <li>Net proceeds will be used for the commercial launch of HTX-011, development of ongoing and future clinical trials and other activities and general corporate purposes.</li><li>Closing date is April 3.</li><li>Shares are down&nbsp;<font color='red'>4%</font>&nbsp;premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3342482\" data-linked=\"Heron Therapeutics down 4% premarket on pricing common stock offering\" data-tweet=\"$HRTX - Heron Therapeutics down 4% premarket on pricing common stock offering https://seekingalpha.com/news/3342482-heron-therapeutics-down-4-premarket-on-pricing-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3342482-heron-therapeutics-down-4-premarket-on-pricing-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342481\" data-ts=\"1522324243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVFY\" target=\"_blank\">NVFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342481-nova-lifestyle-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nova Lifestyle reports Q4 results</a></h4><ul><li>Nova Lifestyle (NASDAQ:<a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a>): Q4 EPS of $0.05</li><li>Revenue of $35.68M (+79.3% Y/Y)</li><li>Shares <font color='green'>+9.31%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17115344-nova-lifestyle-reports-outstanding-fourth-quarter-full-year-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3342481\" data-linked=\"Nova Lifestyle reports Q4 results\" data-tweet=\"$NVFY - Nova Lifestyle reports Q4 results https://seekingalpha.com/news/3342481-nova-lifestyle-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3342481-nova-lifestyle-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342480\" data-ts=\"1522324175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PULM\" target=\"_blank\">PULM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342480-pulmatrix-down-26-premarket-on-pricing-public-offering-of-23_5m-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pulmatrix down 26% premarket on pricing public offering of 23.5M units</a></h4><ul> <li>Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) <a href=\"https://seekingalpha.com/pr/17115146-pulmatrix-announces-pricing-15_2-million-underwritten-public-offering\" target=\"_blank\">prices</a> its public offering of 23.5M units, comprised of one share of common stock and one Series A and one Series B warrant to purchase one share of common stock, for the gross proceeds of ~$15.2M.</li><li>Underwriters over-allotment is an additional&nbsp;1.15M units.</li>                   <li>Each Series A and B warrant has an exercise price of $0.65 and $0.75 per share, respectively.</li>  <li>Net proceeds will be used for R&amp;D of its therapeutic candidates, as well as for working capital and general corporate purposes.</li><li>Closing date is April 3.</li><li>Shares are down&nbsp;<font color='red'>26%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342480\" data-linked=\"Pulmatrix down 26% premarket on pricing public offering of 23.5M units\" data-tweet=\"$PULM - Pulmatrix down 26% premarket on pricing public offering of 23.5M units https://seekingalpha.com/news/3342480-pulmatrix-down-26-premarket-on-pricing-public-offering-of-23_5m-units?source=tweet\" data-url=\"https://seekingalpha.com/news/3342480-pulmatrix-down-26-premarket-on-pricing-public-offering-of-23_5m-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342478\" data-ts=\"1522323976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOV\" target=\"_blank\">MOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342478-movado-positive-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Movado positive post Q4 results</a></h4><ul><li>Movado (NYSE:<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a>) reports net sales rose 10.2%&nbsp;on a constant currency basis in <a href=\"https://seekingalpha.com/pr/17115259-movado-group-inc-announces-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Q4</a>.</li><li>Comparable sales up 6.4% for the quarter.</li><li>Adjusted gross margin rate improved 320 bps to 52.7%, primarily due to favorable changes in foreign currency exchange rates, channel and product mix and a reduction of certain fixed costs.</li><li>Adjusted operating margin rate grew 390 bps to 9.6%.</li><li>Inventory -1% Y/Y to $151.68M.</li><li><b>FY2019 Guidance</b>: Net sales: $605M to $615M; Operating income: ~$68M to $71M; Tax rate: 25%; Net income: ~$50.5M to $52.8M; Diluted EPS: $2.15 to $2.25.</li><li>MOV&nbsp;<font color='green'>+1.20%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342478\" data-linked=\"Movado positive post Q4 results\" data-tweet=\"$MOV - Movado positive post Q4 results https://seekingalpha.com/news/3342478-movado-positive-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3342478-movado-positive-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342473\" data-ts=\"1522323462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342473-shire-marketing-applications-for-hae-med-lanadelumab-accepted-in-europe-and-canada-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire marketing applications for HAE med lanadelumab accepted in Europe and Canada; shares up 1% premarket</a></h4><ul><li>The European Medicines Agency &#40;EMA&#41; has <a href=\"https://seekingalpha.com/pr/17115171-shire-reports-regulatory-milestones-investigational-hereditary-angioedema-hae-treatment\" target=\"_blank\">accepted for review</a> Shire plc's (NASDAQ:<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>) marketing application seeking approval for lanadelumab (SHP643) for the prevention of angioedema attacks in patients at least 12 years old with hereditary angioedema &#40;HAE&#41;. The filing has accelerated review status which shortens the review period to 150 days from the standard 210 days. The action date is on or about August 26.</li><li>Health Canada has also accepted its application under Priority Review status which shortens the review period to 180 days from the standard 300 days. The action date is on or about September 25.</li><li>The company's U.S. application is currently under FDA review with an action date of August 26.</li><li>Lanadelumab is a human monoclonal antibody that binds to (inhibits) an enzyme called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Plasma_kallikrein\" target=\"_blank\">plasma kallikrein</a>&nbsp;that plays a key role in blood pressure regulation, thrombosis and inflammation.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3333718-fda-accepts-shires-lanadelumab-marketing-application-hae-accelerated-review-status\" target=\"_blank\">FDA accepts Shire's lanadelumab marketing application for HAE under accelerated review status</a> (Feb. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3342473\" data-linked=\"Shire marketing applications for HAE med lanadelumab accepted in Europe and Canada; shares up 1% premarket\" data-tweet=\"$SHPG - Shire marketing applications for HAE med lanadelumab accepted in Europe and Canada; shares up 1% premarket https://seekingalpha.com/news/3342473-shire-marketing-applications-for-hae-med-lanadelumab-accepted-in-europe-and-canada-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3342473-shire-marketing-applications-for-hae-med-lanadelumab-accepted-in-europe-and-canada-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342465\" data-ts=\"1522322706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342465-zosano-pharma-readies-stock-offering-shares-down-25-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano Pharma readies stock offering; shares down 25% premarket</a></h4><ul><li>Nano cap Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>) slumps&nbsp;<font color='red'>25%</font>&nbsp;premarket on average volume after the SEC <a href=\"https://www.sec.gov/Archives/edgar/data/1587221/999999999518000698/xslEFFECTX01/primary_doc.xml\" target=\"_blank\">declared </a>its prospectus for a 10M-share <a href=\"https://www.sec.gov/Archives/edgar/data/1587221/000119312518098083/d479354ds1a.htm\" target=\"_blank\">stock offering</a> effective. Price and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342465\" data-linked=\"Zosano Pharma readies stock offering; shares down 25% premarket\" data-tweet=\"$ZSAN - Zosano Pharma readies stock offering; shares down 25% premarket https://seekingalpha.com/news/3342465-zosano-pharma-readies-stock-offering-shares-down-25-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3342465-zosano-pharma-readies-stock-offering-shares-down-25-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342464\" data-ts=\"1522322410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNOV\" target=\"_blank\">MNOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342464-medicinovas-mnminus-166-flunks-mid-stage-methamphetamine-dependence-study-shares-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MediciNova&#39;s MN-166 flunks mid-stage methamphetamine dependence study; shares down 10% premarket</a></h4><ul><li>Thinly traded micro cap MediciNova (NASDAQ:<a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a>) slips&nbsp;<font color='red'>10%&nbsp;</font>premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17115244-medicinova-announces-results-phase-2-clinical-trial-mnminus-166-ibudilast-methamphetamine\" target=\"_blank\">announcement </a>that a Phase 2 clinical trial assessing lead candidate MN-166 (ibudilast) in methamphetamine dependence failed to achieve the primary endpoint of methamphetamine abstinence during the last two weeks of treatment (weeks 11 and 12).</li><li>The company plans to further analyze the data with investigators at UCLA and discuss the results with study sponsor NIH/NIDA. It also intends to meet with the FDA after it receives data from the ongoing methamphetamine use disorder study at Oregon Health &amp; Science University.</li><li>Ibudilast has been sold in Japan and Korea since 1989 to treat post-stroke complications and bronchial asthma. The company says its anti-neuroinflammatory and neuroprotective actions provide the rationale for its use in neurodegenerative disorders (eg. MS and ALS), substance abuse/addiction and chronic neuropathic pain.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342464\" data-linked=\"MediciNova&#39;s MN-166 flunks mid-stage methamphetamine dependence study; shares down 10% premarket\" data-tweet=\"$MNOV - MediciNova&#39;s MN-166 flunks mid-stage methamphetamine dependence study; shares down 10% premarket https://seekingalpha.com/news/3342464-medicinovas-mnminus-166-flunks-mid-stage-methamphetamine-dependence-study-shares-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3342464-medicinovas-mnminus-166-flunks-mid-stage-methamphetamine-dependence-study-shares-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342463\" data-ts=\"1522322387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342463-tesla-looks-to-break-out-of-downtrend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla looks to break out of downtrend</a></h4><ul> <li>KeyBanc is defending Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) in a note published this morning, saying shares are now in oversold territory.</li> <li>Channel checks conducted by the KeyBanc team show Model 3 deliveries displaying an \"improved ramp\" trend compared to the previous checks.</li> <li>Deutsche Bank expects Tesla will miss expectations with its Q1 deliveries tally. The firm reiterates a Hold rating.</li> <li>Nomura trims its price target on Tesla to $420 from $500, while keeping a Buy rating locked in place. The $500 PT was the highest from a major investment firm.</li> <li>Late yesterday, a Delaware judged <a href=\"https://www.bloomberg.com/news/articles/2018-03-28/tesla-investors-can-move-ahead-with-claims-over-solarcity-deal\" target=\"_blank\">ruled</a> that Tesla shareholders could move ahead with a lawsuit over the SolarCity acquisition.</li><li>Sources: Bloomberg, CNBC</li> <li>Shares of Tesla are <font color='green'>up 1.57%</font> premarket to $261.83. The 52-week low for Tesla is $252.10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3342463\" data-linked=\"Tesla looks to break out of downtrend\" data-tweet=\"$TSLA - Tesla looks to break out of downtrend https://seekingalpha.com/news/3342463-tesla-looks-to-break-out-of-downtrend?source=tweet\" data-url=\"https://seekingalpha.com/news/3342463-tesla-looks-to-break-out-of-downtrend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3342445\" data-ts=\"1522321190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TITN\" target=\"_blank\">TITN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3342445-titan-machinery-higher-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Machinery higher on earnings beat</a></h4><ul><li>Titan Machinery (NASDAQ:<a href='https://seekingalpha.com/symbol/TITN' title='Titan Machinery Inc.'>TITN</a>) reports equipment revenue rose 11.3% to $252.61M in <a href=\"https://seekingalpha.com/pr/17115260-titan-machinery-inc-announces-results-fiscal-fourth-quarter-full-year-ended-january-31-2018\" target=\"_blank\">Q4</a>.</li><li>Parts revenue slipped 6.6% to $45.51M.</li><li>Service revenue dropped 5.4% to $26.51M.</li><li>Segment revenue: Agriculture: $205.31M (+2.1%); Construction: $85.77M (+5%); International: $48.53M (+39.4%).</li><li>Gross margin rate -10 bps to 15.3%.</li><li>Operating expense rate improved 170 bps to 14.8%.</li><li><b>FY2019 Guidance</b>:&nbsp;Agriculture sales: 0% to +5%;&nbsp;Construction sales: +3% to +8%;&nbsp;International sales: 0% to +5%; Equipments margins: 7.8% to 8.3%; Diluted EPS: $0.35 to $0.55.</li><li>TITN&nbsp;<font color='green'>+1.77%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3342445\" data-linked=\"Titan Machinery higher on earnings beat\" data-tweet=\"$TITN - Titan Machinery higher on earnings beat https://seekingalpha.com/news/3342445-titan-machinery-higher-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3342445-titan-machinery-higher-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}